Holt Capital Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,238
Closed -$209K 155
2022
Q4
$209K Buy
+2,238
New +$216K 0.04% 154
2018
Q1
Sell
-5,618
Closed -$407K 146
2017
Q4
$407K Hold
5,618
0.13% 103
2017
Q3
$457K Hold
5,618
0.15% 100
2017
Q2
$452K Hold
5,618
0.16% 97
2017
Q1
$441K Sell
5,618
-4,365
-44% -$348K 0.16% 97
2016
Q4
$788K Hold
9,983
0.29% 71
2016
Q3
$888K Buy
9,983
+800
+9% +$75.5K 0.35% 64
2016
Q2
$879K Hold
9,183
0.36% 59
2016
Q1
$953K Buy
9,183
+1,900
+26% +$185K 0.42% 52
2015
Q4
$712K Sell
7,283
-150
-2% -$14.7K 0.32% 62
2015
Q3
$717K Hold
7,433
0.3% 60
2015
Q2
$780K Hold
7,433
0.32% 63
2015
Q1
$767K Hold
7,433
0.31% 59
2014
Q4
$716K Buy
+7,433
New +$655K 0.3% 61

Other funds holding CVS

Holt Capital Partners's CVS Position: Q1 2023 in Review

Holt Capital Partners sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,238 shares — an estimated $209K sold.

Holt Capital Partners first reported a position in CVS in Q4 2014 and held it in 14 quarters. The position peaked at $953K in Q1 2016. 2,270 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Holt Capital Partners reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Holt Capital Partners sold 2,238 CVS Health shares in Q1 2023, an estimated $209K.
  • Holt Capital Partners first reported a position in CVS Health in Q4 2014 and held it in 14 quarters.
  • Holt Capital Partners's CVS Health position peaked at $953K in Q1 2016.
  • 2,270 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Holt Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.